377 related articles for article (PubMed ID: 34047271)
21. mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021.
Nunes B; Rodrigues AP; Kislaya I; Cruz C; Peralta-Santos A; Lima J; Pinto Leite P; Sequeira D; Matias Dias C; Machado A
Euro Surveill; 2021 Sep; 26(38):. PubMed ID: 34558406
[TBL] [Abstract][Full Text] [Related]
22. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
de Gier B; Andeweg S; Backer JA; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
Euro Surveill; 2021 Nov; 26(44):. PubMed ID: 34738514
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
[TBL] [Abstract][Full Text] [Related]
24. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
de Gier B; Andeweg S; Joosten R; Ter Schegget R; Smorenburg N; van de Kassteele J; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
Euro Surveill; 2021 Aug; 26(31):. PubMed ID: 34355689
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran.
Hosseinzadeh A; Sahab-Negah S; Nili S; Aliyari R; Goli S; Fereidouni M; Alami A; Shati M; Ahmadnezhad E; Mehravaran S; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Mahdavi S; Enayatrad M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Hashemi Shahri SM; Dehghan M; Amini Moridani M; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Khodashahi R; Amini M; Jabbari Azad F; Rezaeitalab F; Amel Jamehdar S; Eshraghi A; Sharifi H; Hashemi Bajgani SM; Mahdavi A; Jafarzadeh A; Farokhnia M; Ebrahimi S; Pardakhti A; Ghaderi E; Soltani H; Jadidoleslami S; Arianejad A; Gavili H; Moradveisi B; Motamedi D; Zare H; Kazemi T; Emamian MH
Bull World Health Organ; 2022 Aug; 100(8):474-483. PubMed ID: 35923277
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.
Butt AA; Chemaitelly H; Al Khal A; Coyle PV; Saleh H; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618693
[TBL] [Abstract][Full Text] [Related]
27. [Impact of covid-19 vaccination on hospitalization in a third-level hospital.].
Haro Pérez AM; Benito López VE; Jiménez Rodríguez M; García Yu IA; Martín Monteagudo S
Rev Esp Salud Publica; 2022 Feb; 96():. PubMed ID: 35194012
[TBL] [Abstract][Full Text] [Related]
28. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.
Pardo-Seco J; Mallah N; López-Pérez LR; González-Pérez JM; Rosón B; Otero-Barrós MT; Durán-Parrondo C; Rodríguez-Tenreiro C; Rivero-Calle I; Gómez-Carballa A; Salas A; Martinón-Torres F
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409724
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
[TBL] [Abstract][Full Text] [Related]
31. [Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.].
Gras-Valentí P; Chico-Sánchez P; Algado-Sellés N; Jiménez-Sepúlveda NJ; Gómez-Sotero IL; Fuster-Pérez M; Cartagena-Llopis L; Sánchez-Valero M; Cerezo-Milán P; Martínez-Tornero I; Tremiño-Sánchez L; Nadal-Morante V; Monerris-Palmer M; Esclapez-Martínez A; MorenodeArcos-Fuentes E; Escalada-Martín I; Escribano-Cañadas I; Merino-Lucas E; Rodríguez-Díaz JC; Sánchez-Payá J
Rev Esp Salud Publica; 2021 Apr; 95():. PubMed ID: 33913444
[TBL] [Abstract][Full Text] [Related]
32. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
[TBL] [Abstract][Full Text] [Related]
33. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
Mateo-Urdiales A; Spila Alegiani S; Fabiani M; Pezzotti P; Filia A; Massari M; Riccardo F; Tallon M; Proietti V; Del Manso M; Puopolo M; Spuri M; Morciano C; D'Ancona FP; Da Cas R; Battilomo S; Bella A; Menniti-Ippolito F; ;
Euro Surveill; 2021 Jun; 26(25):. PubMed ID: 34169819
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
Grewal R; Kitchen SA; Nguyen L; Buchan SA; Wilson SE; Costa AP; Kwong JC
BMJ; 2022 Jul; 378():e071502. PubMed ID: 35793826
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
[TBL] [Abstract][Full Text] [Related]
37. Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022.
van Iersel SCJL; McDonald SA; de Gier B; Knol MJ; de Melker HE; Henri van Werkhoven CH; Hahné SJM;
Vaccine; 2023 Jun; 41(26):3847-3854. PubMed ID: 37202273
[TBL] [Abstract][Full Text] [Related]
38. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
Rosero-Bixby L
JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
[TBL] [Abstract][Full Text] [Related]
39. Post-vaccination outcomes in association with four COVID-19 vaccines in the Kingdom of Bahrain.
AlQahtani M; Du X; Bhattacharyya S; Alawadi A; Al Mahmeed H; Al Sayed J; Justman J; El-Sadr WM; Hidary J; Mukherjee S
Sci Rep; 2022 Jun; 12(1):9236. PubMed ID: 35654940
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022.
Castilla J; Lecea Ó; Martín Salas C; Quílez D; Miqueleiz A; Trobajo-Sanmartín C; Navascués A; Martínez-Baz I; Casado I; Burgui C; Egüés N; Ezpeleta G; Ezpeleta C
Euro Surveill; 2022 Aug; 27(33):. PubMed ID: 35983774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
